Spreading Roots
As Georgia State continues to expand the Atlanta Campus with new open space, new buildings and new uses for historic structures, it remains true to a legacy of existing hand in glove as part of the city.
Carra Patterson Has Range
The Alumni Association 40 Under 40 honoree and leading lady in the new Disney+ series "Turner and Hooch" is a star of stage, television and film.
Storied Past
For 88 years, Georgia State’s student newspaper, The Signal, has shone a light on campus life and given young journalists the pages to ply their trade. In this oral history, a handful of Signal alumni tell their tales from the newsroom.
Side Hustles
Law professor Samuel A. Donaldson has published more than 120 puzzles in The New York Times, The Washington Post, The Atlanta Journal-Constitution and more. Take a crack at his latest, and check your answers by clicking the link at the top of the page.
Show All
News
Profiles
Features
Q&As
Research
Fighting Injustice Where It Starts
Taylor Stanley (M.P.P. ’13), granddaughter of ambassador and civil rights activist Andrew Young, is creating long-lasting social change in Atlanta by addressing racial inequity at the youth level through ATL: Advance the Lives.
Making the Pitch
After starting his career at IBM and finding his footing as an entrepreneur, Mohammed Hasan Tarek (B.B.A. ’99) is focusing on his passion for cricket as the owner of one of the sport’s newest professional teams, the Atlanta Fire.
The Braves’ Key Player
Longtime Atlanta Braves organist and Georgia State grad Matthew Kaminski (B.Mu. ’00, M.Mu. ’12) provides the team’s often hilarious in-game soundtrack and clever walkup tunes directed at opposing batters.
The Inside Story
Andrew Gumbel’s prize-winning book “Won’t Lose This Dream: How an Upstart Urban University Rewrote the Rules of a Broken System” recounts Georgia State’s highly successful efforts to level the playing field for students from all backgrounds.
Preparing for the Next Pandemic
A new research center led by Richard Plemper in the Institute for Biomedical Sciences will develop critical antiviral drugs to meet the challenge of existing and newly evolving threats, such as coronaviruses.
